Boisvert, François Michel

Professeur, Faculté de médecine et des sciences de la santé
FMSS Dép. d'immunologie et de biologie cellulaire

Coordonnées

Courriel


819-821-8000, poste 75430

Diplômes

(2011) Protein Analysis of Protein Localization Following DNA Damage. Post-doctorate (Postdoctoral Fellow). University of Dundee.

(2005) A Role for Arginine Methylation in DNA Repair. Doctorate (Ph.D.). McGill University.

(2000) Characterization of PML Nuclear Bodies. Master's Thesis (M.Sc. - Masters). The University of Calgary.

(1998) Bachelor's (B.Sc.). Université de Montréal.

Expérience académique

(2019) Director - Cell Biology MSc/PhD Programs. Université de Sherbrooke.

(2016) Associate Professor/Professeur Agrégé. Université de Sherbrooke.

(2012) Director - Proteomics Facility of the Université de Sherbrooke. Université de Sherbrooke.

(2011-2016) Assistant Professor/Professeur Adjoint. Université de Sherbrooke.

(2005-2011) Post-Doctoral Fellow. University of Dundee.

(2000-2005) Ph.D. Student. McGill University.

(1998-2000) M.Sc. Student. The University of Calgary.

(1998) Summer Student. Université de Montréal.

(1997) Summer Student. Université de Montréal.

Présentation

Sujets de recherche

Cancer of the Digestive System, Cell Signaling and Cancer, Genomic Damage and Repair, Proteins, Proteomics.

Disciplines de recherche

Biochemistry, Cell Biology.

Mots-clés

Arginine Methylation, Biochemistry, Cell Biology, DNA Repair, Mass Spectrometry, Microscopy, Molecular Biology, Nuclear Structures, Nucleus, Transcription.

Intérêts de recherche

We have new evidence showing that DNA damage alters the properties of the MCM complex. The MCM proteins are replicative helicase playing an important role during DNA synthesis and are required for processive DNA replication. I am characterizing these proteins and their nuclear complexes in order to uncover the role of the MCM complex showing potential links to DNA repair.

Centre de recherche

Centre de recherche du CHUS

Langues parlées et écrites

Anglais, Français

Prix et distinctions

  • (2020) Research Scholars - Junior 2 Career salary Award. Fonds de recherche du Québec - Santé (FRQS). (Prize / Award).
  • (2016) Research Scholars - Junior 1 Career salary Award. Fonds de recherche du Québec - Santé (FRQS). (Prize / Award).
  • (2009) Post Doctoral Fellowship. The Royal Society of Edinburgh Foundation. (Prize / Award).
  • (2006) Post-Doctoral Fellowship. Canadian Institutes of Health Research. (Prize / Award).
  • (2005) Post-Doctoral Fellowship (Declined). Canadian Cancer Society Research Institute. (Prize / Award).
  • (2005) Post-Doctoral Fellowship (Declined). Fonds de recherche du Québec - Santé (FRQS). (Prize / Award).
  • (2005) Ph.D. Studentship. Canadian Cancer Society Research Institute. (Prize / Award).
  • (2001) Ph.D. Studentship. Cancer Research Society. (Prize / Award).
  • (2000) M.Sc. Studentship. Alberta Heritage Foundation for Medical Research. (Prize / Award).
  • (1999) M.Sc. Scholarship. The University of Calgary. (Prize / Award).
  • Alma Mater Traval Award. McGill University. (Prize / Award).
  • Dean's Honour List, Ph.D. McGill University. (Distinction).
  • Graduate Student of the Year - Cancer Biology Research Group. The University of Calgary. (Prize / Award).
  • Presentation Award - 3rd Annual McGill Biomedical Graduate Conference. McGill University. (Prize / Award).
  • Tableau d'honneur du doyen 2014. Université de Sherbrooke. (Honor).
  • Tableau d'honneur du doyen 2015. Université de Sherbrooke. (Honor).
  • Tableau d'honneur du doyen 2016. Université de Sherbrooke. (Honor).
  • Tableau d'honneur du doyen 2017. Université de Sherbrooke. (Honor).
  • Travel Award - Proteomics: The Next Grand Biochemical Challenge. Vanderbilt University. (Prize / Award).
  • Young Investigator Award. Canadian Association of Gastroenterology. (Prize / Award).

Financement

Grant. (Awarded). Principal Applicant. Precision medicine: a mass spectrometer for the discovery of new protein biomarkers in cancer and diseases.. Canada Foundation for Innovation (CFI). John R. Evans Leaders Fund. 1589998 $ (2018-2023).

Grant. (Awarded). Principal Applicant. Assembly and function of DNA double-strand break repair foci.. Natural Sciences and Engineering Research Council of Canada (NSERC). Discovery Grants Program - Individual. 210000 $ (2018-2023).

Grant. (Under Review). Principal Applicant. The MCM Complex: At the crossroads of DNA replication and DNA repair.. Canadian Institutes of Health Research (CIHR). Project Grant - Fall 2017 and Spring 2018. 925000 $ (2018-2023).

Grant. (Awarded). Principal Applicant. Ubiquitin-KEKS: Function of a Novel Ubiquitin Isoform Coded by UBBP4, a Gene Initially Annotated as a Pseudogene.. Canadian Institutes of Health Research (CIHR). Project Grant - Fall 2017 and Spring 2018. 891225 $ (2018-2023).

Grant. (Under Review). Co-applicant. Identification des modifications posttraductionnelles et des partenaires d'interaction du domaine intracellulaire de NOTCH1.. Fonds de recherche du Québec - Nature et technologies (FRQNT). Team Grants. 180000 $ (2018-2021).

Grant. (Under Review). Co-applicant. Rôles des RAB GTPases dans l'adressage de cargos lors d'événements de trafic intracellulaire.. Fonds de recherche du Québec - Nature et technologies (FRQNT). Team Grants. 180000 $ (2018-2021).

Grant. (Awarded). Collaborator. Measuring baseline ascorbic acid levels in the optimal vasopressor titration trian (HECHT ID #4410). Lotte & John Hecht Memorial Foundation. InspireHealth Funding Program. 206800 $ (2018-2020).

Grant. (Awarded). Co-applicant. URINE PROTEOMICS: Towards the discovery of potent biomarkers for early diagnosis of bladder cancer.. Merck Sharp & Dohme Research Laboratory. Programme de Subvention Merck/UdeS. 67000 $ (2018-2020).

Scholarship. (Awarded). Principal Applicant. FRQ-S Junior 2 Salary Award. Fonds de recherche du Québec - Santé (FRQS). Junior 2 Scholarships. 295448 $ (2016-2020).

Grant. (Completed). Co-applicant. Impact de la délétion génétique intestin-spécifique de HNF4A (MODY1) sur le métabolisme lipidique.. Centre de Recherche du Centre Hospitalier de l'Université de Sherbrooke Inc. (CRCHUS) (Sherbrooke, QC). PAFI 2018-2019. 25000 $ (2018-2019).

Grant. (Completed). Principal Applicant. Ubiquitination of the MCM-ASF1 complex by DDB1-CUL4 following DNA damage.. Cancer Research Society (The). 2017 Cancer Research Society Competition. 120000 $ (2017-2019).

Grant. (Completed). Principal Investigator. Proteomic Analysis of Human Intestinal Cells. (2012-2018).

Grant. (Completed). Principal Investigator. A mass spectrometer for the establishment of a proteomics facility at the Université de Sherbrooke. (2012-2017).

Grant. (Completed). Principal Applicant. Discovery of prognostic biomarkers for the implementation of personalized treatments for patients with colorectal cancer.. (2015-2017).

Grant. (Completed). Principal Investigator. Identification of the DDB1/CUL4 associated factors ubiquitination targets. Centre de Recherche du Centre Hospitalier de l'Université de Sherbrooke Inc. (CRCHUS) (Sherbrooke, QC). Institutional Bridge Funding. 40000 $ (2016).

Scholarship. (Completed). Principal Applicant. Étude protéomique de la réponse cellulaire aux agents causant des dommages à l'ADN dans le cancer colorectal.. (2012-2016).

Grant. (Completed). Principal Investigator. Subcellular redistribution of proteins following DNA damage: a role for the MCM complex in DNA repair.. (2012-2015).

Grant. (Completed). Principal Applicant. Étude protéomique de la réponse cellulaire aux agents causant des dommages à l'ADN dans le cancer colorectal.. (2012-2015).

Grant. (Completed). Principal Applicant. Soins personnalisés pour les patients avec un cancer du rectum traités par la radiochimiothérapie néoadjuvante à l’aide de biomarqueurs pronostiques. (2014-2015).

Grant. (Completed). Co-applicant. Étude protéomique du complexe NIC1 dans le contexte inflammatoire du cancer pancréatique.. (2013-2014).

Grant. (Completed). Co-applicant. Étude protéomique du complexe NIC1 dans le contexte inflammatoire du cancer pancréatique. (2012-2013).

Contract. (Completed). Principal Investigator. Proteomic Analysis of the Cellular Response to DNA Damage. (2011-2013).

Grant. (Completed). Principal Investigator. Subcellular Redistribution of Proteins Following DNA Damage: A Role for the MCM-ASF1 Complex in DNA Repair. (2012).

Fellowship. (Awarded). Principal Applicant. Characterization of the nucleolar proteome during the cell cycle.. (2006-2009).

Fellowship. (Awarded). Principal Applicant. Characterization of the nucleolar proteome during the cell cycle.. (2005-2006).

Fellowship. (Awarded). Principal Applicant. Characterization of the nucleolar proteome during the cell cycle.. (2005).

Fellowship. (Awarded). Principal Applicant. Post-Doctoral Fellowship (Declined). (2005).

Scholarship. (Awarded). The Prevalence of Sam68 Nuclear Bodies in Breast Cancer. (2001-2005).

Scholarship. (Awarded). The prevalence of Sam68 nuclear bodies in breast cancer.. (2000-2001).

Scholarship. (Awarded). Characterization of Promyelocytic Leukemia Nuclear Bodies.. (1999-2000).

Scholarship. (Awarded). PML Nuclear Bodies.. (1999).

Publications

Articles de revue

  • Lambert, É., Babeu, J.-P., Simoneau, J., Lévesque, D., Jolibois, É., Scott, M., Boudreau, F. and Boisvert, F.-M. (2020). Human HepatocyteNuclear Factor 4-alpha encodes isoforms with distinct transcriptionalfunctions. Molecular & Cellular Proteomics, 1, 1. (Revision Requested).
  • Dahabieh, M.S., Goncalves, C., Khoury, E., Bolt, A., Mann, K.K., Xu, Z.Y. Boisvert, F.-M., Miller Jr., W.H., del Rincon, S.V. (2020). IncreasingPexophagy as an Unconventional Mode to Kill Cancer Cells. Autophagy, 1, 1. (Submitted).
  • Chesnel, F., Couturier, A., Alusse, A., Gagné, J.-P., Poirier, G.G., Jean, D., Boisvert, F.-M., Hascoet, P., Paillard, L., Arlot-Bonnemains, Y. and Le Goff, X. (2020). The prefoldin complexstabilizes the von Hippel-Lindau protein against aggregation and degradation. PLoS Genetics, 1, 1. (Submitted).
  • Dubois, M.-L., Samandi, S., Brunelle, M., Frion, J., Toupin, A., Brunet, M., Jacques, J,-F., Lévesque, D., Scott, M., Lavigne, P., Roucou, X. and Boisvert, F.-M. (2020). UBB Pseudogene 4 encodes novel ubiquitinvariants. Nature Communications, 1, 1. (In Press).
  • Del Olmo T, Lauzier A, Normandin C, Larcher R, Lecours M, Jean D, Lessard L, Steinberg F, Boisvert FM, Jean S. (2019). APEX2-mediated RAB proximity labeling identifies a role for RAB21 in clathrin-independent cargo sorting. Embo Reports, e47192. doi: 10.1525, 1. (Published).
  • Gonneaud A, Turgeon N, Jones C, Couture C, Lévesque D, Boisvert FM, Boudreau F, Asselin C. (2019). HDAC1 and HDAC2 independently regulate common and specific intrinsic responses in murine enteroids. Scientific Reports, 9(1), 1. (Published).
  • Gordon, M.H., *Chauvin, A., Boisvert, F.-M. and MacNaughton W.K. (2019). Proteolytic processing of the epithelial adherens junction molecule E-cadherin by neutrophil elastase generates short peptides with novel wound healing bioactivity. Cellular and Molecular Gastroenterology and Hepatology., 7(2), 483-486. (Published).
  • *Samuel Wilson, Jean-Philippe Babeu, *Romain Drissi, Dominique Lévesque, Francois-Michel Boisvert* and Francois Boudreau* *co-senior authors. (2019). Quantitative Proteomics Identify a Novel DNA-Repair Dependent Protein Interactome of Hepatocyte Nuclear Factor 4? (HNF4?). Cancers (Basel), 11(5), 1. (Published).
  • Del Olmo T, Lacarrière-Keïta C, Normandin C, Jean D, Boisvert FM, Jean S. (2019). RAB21 interacts with TMED10 and modulates its localization and abundance. Biology Open, 8(9), 1. (Published).
  • *Chauvin A, Boisvert FM. (2018). Clinical Proteomics in Colorectal Cancer, a Promising Tool for Improving Personalised Medicine. Proteomes, 6(4), 1. (Published).
  • *Drissi, R., *Chauvin, A., *McKenna, A., Lévesque, D., *Blais-Brochu, S., Jean, D. and Boisvert, F.-M. (2018). Destabilization of the MiniChromosomeMaintenance (MCM) complex modulates the cellular response to DNA double strandbreaks. Cell Cycle, 17(23), 2593-5609. (Published).
  • Brunet, M.A., Brunelle, M., Lucier, J.-F., Delcourt, V., Levesque, M., Grenier, F., Samandi, S., Leblanc, S., Aguilar, J.D., Dufour, P., Jacques, J.-F., Fournier, I., Ouangraoua, A., Scott, M.S., Boisvert, F.-M., Roucou X. (2018). OpenProt: a more comprehensive guide to exploreeukaryotic coding potential and proteomes. Nucleic Acids Research, 10.1093/nar/gky936, 1. (Published).
  • *Telekawa, C., 1Boisvert, F.-M. and 1Bachand, F. 1: Co-corresponding authors. (2018). Proteomic profiling and functional characterization of post-translational modifications of the fission yeast RNA exosome. Nucleic Acids Research, 46(21), 1. (Published).
  • *Chauvin, A., *Mathieu, A.-A., Wang, C.S., Geha, S., Garde-Granger, P., and Boisvert, F.-M. (2018). The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature. Clinical Proteomics, 15(16), 1. (Published).
  • Blain, J., Bédard, J., *Thompson, M., Boisvert, F.-M. and BOUCHER, M.-J. (2017). C-terminal deletion of NOTCH1 intracellular domain (N1ICD)increases its stability but does not amplify and recapitulate N1ICD-dependent signaling. Scientific Reports, 7(1), 1. (Published).
  • Alexis Gonneaud, Claude Asselin, Francois Boudreau and Francois-Michel Boisvert. (2017). Phenotypic Analysis of Organoids by Proteomics. Proteomics, 7(1), 5034. (Published).
  • *Asselin-Mullen, P., *Chauvin, A., *Dubois, M.-L., *Drissi, R., Lévesque, D. and Boisvert, F.-M. (2017). Protein interaction network of alternatively spliced NudCD1 isoforms. Scientific Reports, 7(1), 12987. (Published).
  • *Chauvin, A. and Boisvert, F.-M. (2017). Proteomics analysis of colorectal cancer cell. Methods in Molecular Biology, 1, 1. (Published).
  • Gonneaud, A., Jones, C., Turgeon, N., Lévesque, D., Asselin, C., Boudreau, F. and Boisvert, F.-M. (2016). A SILAC-based method for quantitative proteomic analysis of intestinal organoids. Scientific Reports, 6, 38195. (Published).
  • *Dubois, M.-L., *Drissi, R., Lévesque, D. and Boisvert F.-M. (2016). Comprehensive characterization of Minichromosome Maintenance Complex (MCM) protein interactions using affinity and proximity purifications coupled to mass spectrometry. Journal of Proteome Research, 15(9), 2924-34. (Published).
  • Landry-Voyer AM, Bilodeau S, Bergeron D, Dionne KL, Port SA, Rouleau C, Boisvert FM, Kehlenbach RH, Bachand F. (2016). Human PDCD2L is an export substrate of CRM1 that associates with 40S ribosomal subunit precursors. Molecular and Cellular Biology, Oct 3(MCB.00303), 1-10. (Published).
  • *Mathieu AA, *Ohl-Séguy E, *Dubois ML, Jean D, Jones C, Boudreau F, Boisvert FM. (2016). Subcellular proteomics analysis of different stages of colorectal cancer cell lines. Proteomics, doi: 10.1002/pmic(201600314.), 1-10. (Published).
  • Thandapani, P., Gandin, V., Rouleau, S.G., Garant, J.-M., Boisvert, F.-M., Perreault, J.-P., Topisirovic, I., Richard, S. (2015). Aven recognition of RNA G-quadruplexes regulates the translation of Mixed Lineage Leukemia proteins. eLife, 12(4), 06234. (Published).
  • Benoit Marchand, Dominique Arsenault, Alexandre Raymond-Fleury, Francois-Michel Boisvert and MARIE-JOSÉE BOUCHER. (2015). Glycogen Synthase Kinase-3 (GSK3) inhibition induces pro-survival autophagic signals in human pancreatic cancer cells. Journal of Biological Chemistry, 290(9), 5592-605. (Published).
  • Alexis Gonneaud,Naomie Turgeon, François-Michel Boisvert, Claude Asselin. (2015). Loss of histone deacetylase Hdac1 disrupts metabolic processes in intestinal epithelial cells. FEBS Letters, 14(589), 2776-83. (Published).
  • *Drissi, R., *Dubois, M.-L., Douziech, M. and Boisvert, F.-M. (2015). Quantitative proteomics reveals dynamic interactions of the MCM complex in the cellular response to etoposide induced DNA damage. Molecular and Cellular Proteomics, 14(7), 2002-13. (Published).
  • Vanderperre B , Lucier JF , Bissonnette C , Motard J , Tremblay G , Vanderperre S , Wisztorski M , Salzet M , Boisvert FM , Roucou X. (2013). Direct detection of alternative open reading frames translation products in human significantly expands the proteome. PloS one, 8(8), 1-12. (Published).
  • *Drissi R , *Dubois ML , Boisvert FM. (2013). Proteomics methods for subcellular proteome analysis. The FEBS journal, 280(22), 5626-5634. (Published).
  • Boisvert FM , Ahmad Y , Gierli?ski M , Charrière F , Lamont D , Scott M , Barton G , Lamond AI. (2012). A quantitative spatial proteomics analysis of proteome turnover in human cells. Molecular & cellular proteomics : MCP, 11(3), 1-15. (Published).
  • Ahmad Y* , Boisvert FM* , Lundberg E , Uhlen M , Lamond AI * Co-First Authors. (2012). Systematic analysis of protein pools, isoforms, and modifications affecting turnover and subcellular localization. Molecular & cellular proteomics : MCP, 11(3), 1-15. (Published).
  • Dixon MJ , Gray A , Boisvert FM , Agacan M , Morrice NA , Gourlay R , Leslie NR , Downes CP , Batty IH. (2011). A screen for novel phosphoinositide 3-kinase effector proteins. Molecular & cellular proteomics : MCP, 10(4), 1-14. (Published).
  • Kliszczak AE , Rainey MD , Harhen B , Boisvert FM , Santocanale C. (2011). DNA mediated chromatin pull-down for the study of chromatin replication. Scientific reports, 1, 1-7. (Published).
  • Scott MS , Boisvert FM , Lamond AI , Barton GJ. (2011). PNAC: a protein nucleolar association classifier. BMC genomics, 12, 1-25. (Published).
  • Moore HM , Bai B , Boisvert FM , Latonen L , Rantanen V , Simpson JC , Pepperkok R , Lamond AI , Laiho M. (2011). Quantitative proteomics and dynamic imaging of the nucleolus reveal distinct responses to UV and ionizing radiation. Molecular & cellular proteomics : MCP, 10(10), 1-15. (Published).
  • Boisvert FM , Lam YW , Lamont D , Lamond AI. (2010). A quantitative proteomics analysis of subcellular proteome localization and changes induced by DNA damage. Molecular & cellular proteomics : MCP, 9(3), 457-470. (Published).
  • Scott MS , Boisvert FM , McDowall MD , Lamond AI , Barton GJ. (2010). Characterization and prediction of protein nucleolar localization sequences. Nucleic acids research, 38(21), 7388-7399. (Published).
  • Chamousset D , Mamane S , Boisvert FM , Trinkle-Mulcahy L. (2010). Efficient extraction of nucleolar proteins for interactome analyses. Proteomics, 10(16), 3045-3050. (Published).
  • Chamousset D , De Wever V , Moorhead GB , Chen Y , Boisvert FM , Lamond AI , Trinkle-Mulcahy L. (2010). RRP1B targets PP1 to mammalian cell nucleoli and is associated with Pre-60S ribosomal subunits. Molecular biology of the cell, 21(23), 4212-26. (Published).
  • Boulon S , Westman BJ , Hutten S , Boisvert FM , Lamond AI. (2010). The nucleolus under stress. Molecular cell, 40(2), 216-227. (Published).
  • Boisvert FM , Lamond AI. (2010). p53-Dependent subcellular proteome localization following DNA damage. Proteomics, 10(22), 4087-4097. (Published).
  • Ahmad Y , Boisvert FM , Gregor P , Cobley A , Lamond AI. (2009). NOPdb: Nucleolar Proteome Database--2008 update. Nucleic acids research, 37, 181-184.
  • Trinkle-Mulcahy L , Boulon S , Lam YW , Urcia R , Boisvert FM , Vandermoere F , Morrice NA , Swift S , Rothbauer U , Leonhardt H , Lamond A. (2008). Identifying specific protein interaction partners using quantitative mass spectrometry and bead proteomes. The Journal of cell biology, 183(2), 223-239.
  • Boisvert FM , van Koningsbruggen S , Navascués J , Lamond AI. (2007). The multifunctional nucleolus. Nature reviews. Molecular cell biology, 8(7), 574-585.
  • Gonsalvez GB , Tian L , Ospina JK , Boisvert FM , Lamond AI , Matera AG. (2007). Two distinct arginine methyltransferases are required for biogenesis of Sm-class ribonucleoproteins. The Journal of cell biology, 178(5), 733-740.
  • Boisvert FM , Déry U , Masson JY , Richard S. (2005). Arginine methylation of MRE11 by PRMT1 is required for DNA damage checkpoint control. Genes & development, 19(6), 671-676.
  • Boisvert FM , Hendzel MJ , Masson JY , Richard S. (2005). Methylation of MRE11 regulates its nuclear compartmentalization. Cell cycle (Georgetown, Tex.), 4(7), 981-989.
  • Boisvert FM , Chénard CA , Richard S. (2005). Protein interfaces in signaling regulated by arginine methylation. Science's STKE : signal transduction knowledge environment, 2005(271), 1-11.
  • Boisvert FM , Rhie A , Richard S , Doherty AJ. (2005). The GAR motif of 53BP1 is arginine methylated by PRMT1 and is necessary for 53BP1 DNA binding activity. Cell cycle (Georgetown, Tex.), 4(12), 1834-1841.
  • Boisvert FM , Déry U , Masson JY , Richard S. (2005). [A new role for arginine methylation in DNA repair]. Médecine sciences : M/S, 21(6-7), 579-581. (Published).
  • Boisvert FM , Richard S. (2004). Arginine methylation regulates the cytokine response. Molecular cell, 15(4), 492-494.
  • Boisvert FM , Côté J , Boulanger MC , Richard S. (2003). A proteomic analysis of arginine-methylated protein complexes. Molecular & cellular proteomics : MCP, 2(12), 1319-1330.
  • Côté J , Boisvert FM , Boulanger MC , Bedford MT , Richard S. (2003). Sam68 RNA binding protein is an in vivo substrate for protein arginine N-methyltransferase 1. Molecular biology of the cell, 14(1), 274-287.
  • Vieyra D , Loewith R , Scott M , Bonnefin P , Boisvert FM , Cheema P , Pastyryeva S , Meijer M , Johnston RN , Bazett-Jones DP , McMahon S , Cole MD , Young D , Riabowol K. (2002). Human ING1 proteins differentially regulate histone acetylation. The Journal of biological chemistry, 277(33), 29832-9. (Published).
  • Boisvert FM , Cote J , Boulanger MC , Cleroux P , Bachand F , Autexier C , Richard S. (2002). Symmetrical dimethylarginine methylation is required for the localization of SMN in Cajal bodies and pre-mRNA splicing. The Journal of cell biology, 159(6), 957-969.
  • Bachand F , Boisvert FM , Côté J , Richard S , Autexier C. (2002). The product of the survival of motor neuron (SMN) gene is a human telomerase-associated protein. Molecular biology of the cell, 13(9), 3192-3202.
  • Côté F , Boisvert FM , Grondin B , Bazinet M , Goodyer CG , Bazett-Jones DP , Aubry M. (2001). Alternative promoter usage and splicing of ZNF74 multifinger gene produce protein isoforms with a different repressor activity and nuclear partitioning. DNA and cell biology, 20(3), 159-173.
  • Hendzel MJ , Kruhlak MJ , MacLean NA , Boisvert F , Lever MA , Bazett-Jones DP. (2001). Compartmentalization of regulatory proteins in the cell nucleus. The Journal of steroid biochemistry and molecular biology, 76(1-5), 9-21. (Published).
  • Wheaton K , Sampsel K , Boisvert FM , Davy A , Robbins S , Riabowol K. (2001). Loss of functional caveolae during senescence of human fibroblasts. Journal of cellular physiology, 187(2), 226-235.
  • Boisvert FM , Kruhlak MJ , Box AK , Hendzel MJ , Bazett-Jones DP. (2001). The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. The Journal of cell biology, 152(5), 1099-1106.
  • Scott M , Bonnefin P , Vieyra D , Boisvert FM , Young D , Bazett-Jones DP , Riabowol K. (2001). UV-induced binding of ING1 to PCNA regulates the induction of apoptosis. Journal of cell science, 114(Pt 19), 3455-3462.
  • Scott M , Boisvert FM , Vieyra D , Johnston RN , Bazett-Jones DP , Riabowol K. (2001). UV induces nucleolar translocation of ING1 through two distinct nucleolar targeting sequences. Nucleic acids research, 29(10), 2052-2058.
  • Boisvert FM , Hendzel MJ , Bazett-Jones DP. (2000). Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. The Journal of cell biology, 148(2), 283-292.
  • Chen T , Boisvert FM , Bazett-Jones DP , Richard S. (1999). A role for the GSG domain in localizing Sam68 to novel nuclear structures in cancer cell lines. Molecular biology of the cell, 10(9), 3015-3033.
  • Hendzel MJ , Boisvert F , Bazett-Jones DP. (1999). Direct visualization of a protein nuclear architecture. Molecular biology of the cell, 10(6), 2051-2062.

Chapitres de livre

  • *Chauvin, A. and Boisvert, F.-M. (2017). Proteomics analysis of colorectal cancer cell. Jean-Francois Beaulieu Colorectal Cancer: Methods and Protocols. Methods in Molecular Biology United States : Springer Editions. (In Press).
  • Dubois, M.-L. and Boisvert, F.-M. (2016). The Dynamic Functions of the Nucleolus. David P. Bazett-Jones The Nucleus. (Springer Editions, 1-20). United States : Springer Publishing. (Published).
  • Boisvert, F.-M. (2013). Chapter 1072: Nucleolus. Stanley Maloy,Kelly Hughes Brenner's Encyclopedia of Genetics (2nd Edition, 1-22). United States : Elsevier Editions. (Published).
  • Hutton, s., Westman, B.J., Boisvert, F.-M., van Koningsbruggen, S. and Lamond, A.I. (2012). Chapter 12: The Nucleolus. Karsten Rippe Genome Organization and Function in the Mammalian Cell Nucleus (279-295). Germany : Wiley-VCH. (Published).
  • Boisvert, F.-M., Ahmad, Y. and Lamond, A.I. (2011). Chapter 20: The Dynamic Proteome of the Nucleolus. Mark Olson The Nucleolus. (347-366). United States : Springer Editions. (Published).

Ressources en ligne

  • Boisvert, F.-M., Ahmad, Y., and Lamond, A.I. (2012). Protein Turnover Viewer. Site Web.
  • Scott, M., Boisvert, F.-M., Lamond, A.I. and Barton, G.J. (2011). Nucleolar Localization Sequence Detector. Site Web.
  • Larance, M., Ten O Have, S., Ahmad, Y., Boisvert, F.-M., and Lamond, A.I. (2011). The Cell Biologist's Guide to Proteomics. Site Web.

Articles de conférence

  • *Chauvin, A. and Boisvert, F.-M. (2018). De nouveaux biomarqueurs pour prédire la résistance à laradio-chimiothérapie néoadjuvante au 5-fluorouracile dans le cancer rectal. 60ème réunion annuelle du CRCQ. (Accepted).
  • Gordon, M.H., *Chauvin, A., Boisvert, F.-M. and MacNaughton, W. (2018). Inflammatory proteases drive a migratory intestinal epithelial phenotype through the generation of bioactive peptide fragments of E-Cadherin. Canadian Digestive Week (CDDW). (Accepted).
  • *Lambert, É., Babeu, J.-P., *Jolibois, É., Lévesque, D., Boudreau, F. and Boisvert, F.-M. (2018). La panoplie d’isoformes du récepteur nucléaire HNF4? diffèrent au niveau de leurs fonctions transcriptionnelles et leurs réseaux d’interactions protéiques. Journée Scientifique de la Faculté de Médecine et des Sciences de la Santé. (Accepted).
  • *Chauvin, A. and Boisvert, F.-M. (2018). La réponse à la radio-chimiothérapie dans le cancer rectal – Une signature protéique prédictive. 1er colloque de biologie cellulaire du Département d’Anatomie et de Biologie Cellulaire. (Accepted).
  • *Chauvin, A., Wang, C.-S., Geha, S., Garde-Granger, P. and Boisvert, F.-M. (2018). La résistance au traitement dans le cancer rectal : implication potentielle des voies de survie/nécroptose médiées par RIPK1. Signalisation Québec 2018. (Accepted).
  • *Chauvin, A., Wang, C.-S., Geha, S., Garde-Granger, P. and Boisvert, F.-M. (2018). La résistance au traitement dans le cancer rectal : implication potentielle des voies de survie/nécroptose médiées par RIPK1. 47ème Journée Scientifique de la Faculté de Médecine et des Sciences de la Santé. (Accepted).
  • *Lambert, É., Babeu, J.-P., *Jolibois, É., Lévesque, D., Boudreau, F. and Boisvert, F.-M. (2018). Les 12 variants de HNF4? possèdent des fonctions transcriptionnelles et des réseaux d’interactions protéiques distincts. Signalisation Québec. (Accepted).
  • *Lambert, É., Babeu, J.-P., Lévesque, D., Boudreau, F. and Boisvert, F.-M. (2018). Role of the nuclear receptor HNF4? and its many isoforms in colorectal cancer. Canadian Digestive Diseases Week. (Accepted).
  • *Lambert, É., Babeu, J.-P., Lévesque, D., Boudreau, F. and Boisvert, F.-M. (2018). Role of the nuclear receptor HNF4? isoforms in colorectal cancer. Research topics - Canadian Association for Gastroenterology. (Accepted).
  • *Dubois, M.-L., Delattre, P., Delcourt. V., Beaudouin, M., Brunelle, M., Samandi, S., Lavigne, P., Roucou, X., Boisvert F.-M. (2018). UBKEKS: Découverte d’un nouveau variant d’ubiquitine qui ne cible pas les protéines au protéasome. Signalisation Québec. (Accepted).
  • *Dubois, M.-L., Delattre, P., Beaudouin, M., Brunelle, M., Jacques, J.-F., Lévesque, D., Samandi, S., Lavigne, P., Roucou, X., Boisvert F.-M. (2018). UBKEKS: Découverte d’un nouveau variant d’ubiquitine qui ne cible pas les protéines au protéasome. 60ème réunion annuelle du CRCQ. (Accepted).
  • *Dubois, M.-L., Delattre, P., Beaudouin, M., Brunelle, M., Jacques, J.-F., Lévesque, D., Samandi, S., Lavigne, P., Roucou, X., Boisvert F.-M. (2018). UbKEKS, a novel Ubiquitin isoform. OpenProt symposium. (Accepted).
  • *Dubois, M.-L., Delattre, P., Beaudouin, M., Brunelle, M., Jacques, J.-F., Lévesque, D., Samandi, S., Lavigne, P., Roucou, X., Boisvert F.-M. (2018). UbKEKS, une nouvelle isoforme de l’ubiquitine. Université d'Alger. (Accepted).
  • *Dubois, M.-L., Delattre, P., Beaudouin, M., Brunelle, M., Jacques, J.-F., Lévesque, D., Samandi, S., Lavigne, P., Roucou, X., Boisvert F.-M. (2018). UbKEKS: a novel ubiquitin variant expressed from a pseudogene. Human Proteome Organization World Congress. (Accepted).
  • *Lambert, E., Babeu, J.P., Lévesque, D., Boisvert, F.-M. and Boudreau, F. (2017). Caractérisation fonctionnelle de l’ensemble des isoformes de HNF4?. Journée scientifique de la FMSS. (Published).
  • *Lambert, E. Babeu, J.P., Boisvert, F.-M. and Boudreau, F. (2017). Caractérisation fonctionnelle des 12 isoformes du récepteur nucléaire HNF4?. CRCQ 2017. (Submitted).
  • *Chauvin A., Wang C.-S., Geha S., Garde-Granger P., Boisvert F.-M. (2017). Determination of a proteomic signature of the response to neoadjuvant radio-chemotherapy in colorectal cancer patients. Canadian Digestive Week (CDDW). (Published).
  • *Chauvin A., Wang C.-S., Geha S., Garde-Granger P., Boisvert F.-M. (2017). Détermination d’une signature protéomique prédictive de la réponse à la radio-chimiothérapie néoadjuvante au5-fluorouracil chez des patients atteints de cancer colorectal de stade III-IV. 46ème édition de la journée scientifique de la FMSS. (Published).
  • *Chauvin A., Wang C.-S., Geha S., Garde-Granger P., Boisvert F.-M. (2017). Identification de biomarqueurs protéiques prédictifs de la réponse à la radio-chimiothérapie néoadjuvante chez des patients atteints de cancer colorectal. 2ème édition du Symposium Proteomeus. (Published).
  • *Wilson, S., Babeu, J.-P,. Boisvert, F.-M., Boudreau F. (2017). L’interaction entre HNF4alpha et les protéines de réparation de l’ADN : un lien exploitable pour le traitement du cancer colorectal?. Club de recherches cliniques du Québec (CRCQ). (Submitted).
  • *Wilson, S., Babeu, J.-P., Boisvert, F.-M., Boudreau, F. (2017). Newly identified interacting proteins of HNF4? reveal a novel DNA repair role in colorectal cancer. Proteomeus 2017. (Published).
  • *Wilson, S., Babeu, J.-P., Boisvert, F.-M., Boudreau, F. (2017). The P2 isoform class of the transcription factor HNF4alpha plays DNA repair role in colorectal cancer. Research Topics in GI Disease Meeting. (Published).
  • *Wilson, S., Babeu, J.-P., Boisvert, F.-M., Boudreau, F. (2017). The P2 isoform class of the transcription factor HNF4alpha plays DNA repair role in colorectal cancer. Canadian Digestive Diseases Week 2017. (Published).
  • *Dubois, M.-L., Lévesques, D. and Boisvert, F.-M. (2016). A role for the MCM complex during the cellular response to DNA damage. Mammalian DNA Repair: Gordon Research Conference. (Published).
  • *Wilson, S., Babeu J.-P., Boisvert, F.-M., and Boudreau, F. (2016). HNF4alpha aurait un rôle potentiel dans les mécanismes de réparation de l’ADN lors du cancer colorectal. CRCQ 2016. (Published).
  • *McKenna, A., *Dubois,M.-L., Lévesque, D. and Boisvert, F.-M. (2016). Identification des cibles du complexe d'ubiquitine ligase DDB1-Cul4 l'aide des protéines adaptatrice DCAF. Signalisation Québec 2016. (Published).
  • *Lacasse, V., Lévesque, D., Wang, C-S., Garde-Granger, P., Geha, S., Boisvert, F-M. (2016). Identification des voies de signalisation dérégulées pour l’identification de biomarqueurs prédictifs de la réponse au traitement du cancer colorectal. Signalisation Québec 2016. (Published).
  • *Drissi, R., Jean, D., and Boisvert, F.-M. (2016). Le complexe MCM et la réponse aux cassures doubles brins de l'ADN. ACFAS. (Published).
  • *Dubois, M.-L. Lévesque, D., and Boisvert, F.-M. (2016). Une étude quantitative de spectrométrie de masse a révélé une dynamique d’interaction pour les protéines MCM en réponse aux dommages à l’ADN. Symposium Protéomeus. (Published).
  • *Dubois, M.-L. *Mckenna, A., *Lacasse, V., Lévesque, D., and Boisvert, F.-M. (2016). Étude du complexe d'ubiquitine ligase DDB1-Cullin4. 45e Journée scientifique de la FMSS. (Published).
  • *Dubois, M.-L., Lévesque, D. and Boisvert, F.-M. (2015). A role for the MCM complex during the cellular response to DNA damage. Mammalian DNA Repair : Gordon Research Conference. (Published).
  • *Asselin-Mullen, P., Lévesque, D. and Boisvert, F.-M. (2015). Caractérisation des fonctions moléculaires des isoformes de NudCD1. Journée Scientifique de la Faculté de Médecine et des Sciences de la Santé – 44e édition. (Published).
  • *Asselin-Mullen, P., Lévesque, D. and Boisvert, F.-M. (2015). Characterization of the molecular functions of NudCD1 isoforms in colorectal cancer cell lines. 2015 CAG Canadian Digestive Diseases Week Winter Meeting. (Published).
  • St-Jean, S., Boisvert, F.-M. and Boudreau, F. (2015). Identification of CHD8 interacting with the transcriptional repressor NCoR. Canadian Journal of Gastroenterology and Hepatology. CDDW 2015. (Published).
  • *Drissi, R., Jean, D. and Boisvert, F.-M. (2015). Implication du complexe MCM dans la réponse aux cassures double brin de l'ADN. 44e Journée scientifique de la FMSS. (Published).
  • *Dubois, M.-L., Lévesque, D. and Boisvert, F.-M. (2015). Interactions et modifications post-traductionnelles des protéines MCM suite aux dommages àl’ADN. 44e Journée Scientifique de la Faculté de Médecine et des Sciences de la Santé de l’université de Sherbrooke. (Published).
  • *Thompson, M., Douziech, M., Arsenault, D., Boucher, M.-J. and Boisvert, F.-M. (2015). Proteomic analysis of NOTCH1: Establishment of a reliable system to identify new NOTCH1 interacting partners. Canadian Digestive Disease Week 2015. (Published).
  • *Dubois, M.-L. and Boisvert, F.-M. (2015). Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage. Canadian Cancer Research Conference. (Accepted).
  • Babeu, J.-P., Carrier, J., Boisvert, F.-M. and Boudreau, F. (2015). Transcriptomic and proteomic analysis of HNF4alpha isoforms functions support opposite roles for these during colon cancer. Canadian Journal of Gastroenterology and Hepatology (CDDW 2015). (Published).
  • *Drissi, R., Jean, D. and Boisvert, F.-M. (2014). Implication des protéines MCM2 et MCM3 dans les mécanismes de réparation des cassures double brin de l'ADN. 43e Journée scientifique de la FMSS. (Published).
  • Babeu, J.-P., Boisvert, F.-M. and Boudreau, F. (2014). Optimization of a SILAC quantitative proteomic approach to identify specific interacting cofactors of HNF4alpha P1 and P2 isoforms. Canadian Journal of Gastroenterology and Hepatology (CDDW 2014). (Published).
  • *Mathieu, A.-A., *Drissi, R., *Ohl-Séguy, E. and Boisvert F.-M. (2014). Proteomic analysis of different stages of colorectal cancer cell lines and tissues. 2014 Research Topics in GI Disease. (Accepted).
  • *Asselin-Mullen, P., Lévesque, D. and Boisvert, F.-M. (2014). Rôle des différentes isoformes de NudCD1 dans le cancer colorectal. Symposium de la recherche sur le cancer. (Published).
  • *Asselin-Mullen, P., Lévesque, D. and Boisvert, F.-M. (2014). Rôle des différentes isoformes de NudCD1 dans le cancer colorectal. Journée Scientifique de la Faculté de Médecine et des Sciences de la Santé – 43e édition. (Published).
  • *Asselin-Mullen, P., Lévesque, D. et Boisvert, F.-M. (2014). Rôle des différentes isoformes de NudCD1 dans le cancer colorectal. Journée Phare Rencontre interuniversitaire en pharmacologie – 6e édition. (Published).
  • *Dubois, M.-L., Lévesques, D. and Boisvert, F.-M. (2014). Étude des domaines d’interactions de la protéine MCM2 avec ASF1 par fragmentome quantitatif. 43e Journée Scientifique de la Faculté de Médecine et des Sciences de la Santé de l’université de Sherbrooke. (Published).
  • *Dubois, M.-L., Lévesques, D. and Boisvert, F.-M. (2014). Étude des domaines d’interactions de la protéine MCM2 par fragmentome quantitatif. Signalisation Québec. (Published).
  • *Dubois, M.-L., Lévesques, D. and Boisvert, F.-M. (2014). Étude des domaines d’interactions de la protéine MCM2 par fragmentome quantitatif. Journée phare 6e édition. (Published).
  • *Asselin-Mullen, P. and Boisvert, F.-M. (2013). Analyse des partenaires d’interaction de MCM2 par spectrométrie de masse. 9ième Journée Scientifique de la Faculté de Médecine et des Sciences de la Santé, Sherbrooke. (Published).
  • *Thompson, M., Douziech, M., Boisvert, F.-M. and Boucher, M.-J. (2013). Analyse protéomique des partenaires d’interaction de Notch1: identification du complexe médiateur. Club de Recherches Cliniques du Québec, Lac Delage, Québec, Canada. (Published).
  • *Thompson, M., Douziech, M., Boisvert, F.-M. and Boucher,M.-J. (2013). Analyse protéomique des partenaires d’interaction de Notch1: identification du complexe médiateur. 9e Journée Scientifique du 1er cycle. (Published).
  • *Thompson, M., Douziech, M.,Boisvert, F.-M. and Boucher, M.-J. (2013). Analyse protéomique des partenaires d’interaction de Notch1: identification du complexe médiateur. Journée Phare, Magog-Orford, Québec, Canada. (Accepted).
  • *Uribe Marioni, L. L. and Boisvert, F.-M. (2013). Characterization of the MCM complex in response to DNA damage. University of Chihuahua. (Published).
  • *Thompson, M., Douziech, M., Boisvert, F.-M. and Boucher,M.-J. (2013). Identification de nouveaux partenaires d’interaction du fragment actif de Notch1 par spectrométrie de masse. Symposium d’ouverture des Conférences Interdisciplinaires sur le Cancer (CIC). (Published).
  • *Drissi, R. and Boisvert, F.-M. (2013). Proteomic analysis of different stages of colorectal cancer cell lines. Canadian Digestive Disease Week 2013. (Published).
  • *Asselin-Mullen, P. and Boisvert, F.-M. (2013). Proteomic analysis of protein interactions of the MCM complex through the cell cycle. 10th Symposium on the Physiology and Diseases of the Digestive Tract. (Published).
  • *Dubois, M.-L., Douziech, M. and Boisvert, F.-M. (2013). Role and interaction of proteins MCM during DNA repair. Canadian Digestive Disease Week 2013. (Published).
  • *Dubois, M.-L., *Drissi,R., Douziech, M., Boisvert, F.-M. (2013). Role and interaction of proteins MCM during DNA repair. Research Topics in GI Disease XII. (Published).
  • *Dubois, M.-L., Douziech, M. and Boisvert, F.-M. (2012). Interaction des proteins du complexe MCM dans les mécanismes de reparation de l’ADN. Journée Scientifique de la Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke. (Published).
  • *Dubois, M.-L., Douziech, M. and Boisvert, F.-M. (2012). Interaction of MCM proteins during DNA repair. 4th Annual Edtion of La Journée Phare. (Published).
  • Boisvert, F.-M. (2012). Proteomic analysis of different stages of colorectal cancer cell lines. CIHR New Principal Investigator Meeting – Institute of Nutrition, Metabolism and Diabetes. (Published).
  • Boisvert, F.-M. (2011). Changes in Subcellular Proteome Localization in Response to DNA Damage. CIHR-ICR New Principal Investigator Meeting. CCRA’s Canadian Cancer Research Conference. (Published).
  • Ahmad, Y., Boisvert, F.-M. and Lamond, A. (2011). PepTracker: A Peptide Analysis Software. 3rd MaxQuant Summer School. (Published).
  • Ly, T., Boisvert, F.-M., Ahmad, Y., Larance, M. and Lamond, A.I. (2011). Revealing the Dynamics of the Acute Promyelocytic Leukemia Proteome Using Subcellular Fractionation, SILAC and Mass Spectrometry. 59th ASMS Conference on Mass Spectrometry and Allied Topics. (Published).
  • Boisvert, F.-M., Ahmad, Y., and Lamond, A.I. (2011). The Dynamic Proteome of the Nucleolus. Wellcome Trust Annual Retreat. (Published).
  • Boisvert, F.-M., Ahmad, Y. and Lamond, A.I. (2010). A Quantitative Approach for Measuring Protein Turnover in Different Subcellular Compartments. Prospect Network Annual Meeting. (Published).
  • Boisvert, F.-M., Lam, Y.W. and Lamond, A.I. (2009). Spatial Proteomics: A Quantitative Approach for Measuring the Subcellular Localization of the Proteome. Prospect Network Annual Meeting. (Published).
  • Boisvert, F.-M. Lam, Y.W. and Lamond A. (2006). Changes in the Nucleolar Proteome Through the Cell Cycle. EMBO Workshop 2006: The Nucleolus: New Perspectives. (Published).
  • Boisvert, F.-M., Côté, J. and Richard S. (2004). Arginine Methylation Targets the MRE11/RAD50/NBS1 Complex to Sites of DNA Damage. Fourth Annual McGill Biomedical Graduate Conference (AMBGC). (Published).
  • Boisvert, F.-M., Côté, J. and Richard S. (2004). Arginine Methylation Targets the MRE11/RAD50/NBS1 Complex to Sites of DNA Damage. Sixth Conference on Signalling in Normal and Cancer Cells. (Published).
  • Richard, S., Dery, U., Masson, JY and Boisvert, F.-M. (2004). A role for arginine methylation in DNA repair. Conference on DNA repair & mutagenesis: From molecular structure to biological consequences (ASM). (Published).
  • Boisvert, F.-M., Côté, J., Boulanger, M.-C. and Richard S. (2003). Arginine methylation is required for the localization of SMN in Cajal bodies and pre-mRNA splicing. Third Annual McGill Biomedical Graduate Conference (AMBGC). (Published).
  • Côté, J., Boisvert, F.-M., Boulanger, M.-C. and Richard S. (2003). The Role of Arginine Methylation in pre-mRNA Splicing. 8th Annual Meeting of the RNA Society. (Published).
  • Boisvert, F.-M., Côté, J. and Richard, S. (2002). Analysis of Arginine Methylation Using MALDI-TOF Mass Spectrometry. Proteomics: The Next Biological Challenge. (Published).
  • Côté, J., Boisvert, F.-M., Boulanger, M.-C., Bedford, M.T. and Richard, S. (2002). Arginine Methylation Mediates the Maturation of the Sam68 RNA Binding Protein. 7th Annual RNA Society Meeting. (Published).
  • Côté, J., Boisvert, F.-M., Boulanger, M.-C., Bedford, M.T. and Richard, S. (2002). Arginine Methylation Mediates the Maturation of the Sam68 RNA Binding Protein. Ribo Club Annual Meeting. (Published).
  • Boisvert, F.-M., Côté, J., Boulanger, M.-C. and Richard S. (2002). Arginine methylation is required for the localization of SMN in Cajal bodies and pre-mRNA splicing. Dynamic Organization of Nuclear Function Meeting. (Published).
  • Boisvert, F.-M., Côté, J., Boulanger, M.-C. and Richard S. (2002). Arginine methylation is required for the localization of SMN in Cajal bodies and pre-mRNA splicing. Ribo Club Annual Meeting. (Published).
  • Boisvert, F.-M., Côté, J., Boulanger, M.-C. and Richard, S. (2002). Regulation of snRNPs Function and Localization by Arginine Methylation. 7th Annual RNA Society Meeting. (Published).
  • Boisvert, F.-M., Martchenko, M., Côté, J. and Richard, S. (2001). Identification of Sam68 in vivo RNA targets. Ribo Club Annual Meeting. (Published).
  • Scott, M., Boisvert, F.-M., Parr, E., Bazett-Jones, D.P. and Riabowol, K.T. (2000). The Candidate Tumor Suppressor Protein p33ING1b Interacts with PCNA and Translocates to the Nucleoli in Response to UV Irradiation. Tumor Suppressor and Oncogene. (Published).
  • Boisvert, F.-M., Hendzel, M. J. and Bazett-Jones, D. P. (1999). Characterization of a Nuclear Structure Highly Enriched in CBP : the PML Body. Winter symposium on RNA: transcription, processing and export. (Published).
  • Guévremont, M., Grondin, B., Ravassard, P., Côté, F., Boisvert, F.-M., Bazinet, M. Mallet, J. and Aubry, M. (1999). Dual nuclear function of ZNF74 KRAB multifinger protein, a candidate for DiGeorge/velocardiofacial syndrome. Winter Symposium on RNA: transcription, processing and export. (Published).
  • Aubry, M., Grondin, B., Ravassard, P., Côté, F., Guèvremont, M., Boisvert, F.-M., Bazinet, M. and Mallet, J. (1999). Dual nuclear function of ZNF74 multifinger protein, a candidate for DiGeorge/Velocardiofacial syndrome. IVth Rencontre IRCM/Institut Pasteur. (Published).
  • Scott, M., Boisvert F.-M., Parr, E., and Riabowol, K.T. (1999). Subnuclear localization of the ING1 candidate tumor suppressor proteins. Alberta Cancer Board Annual Research Meeting. (Published).
  • Boisvert, F.-M., Kruhlak, M.J., and Bazett-Jones, D.P. (1999). The Co-Activator CBP is an active component of PML Nuclear Bodies in Transformed Cells. Alberta Cancer Board Annual Research Meeting. (Published).
  • Grondin, B., Côté, F., Bazinet, M., Boisvert, F.-M., Vincent, M. and Aubry,M. (1997). Direct interaction of the KRAB/Cys2His2 zinc finger protein ZNF74 with a hyperphosphorylated form of the RNA polymerase II largest subunit. Molecular Biology of the Cell. (Published).

Autres contributions

Présentations

  • (2019). More ubiquitins than meets the eye: Novel variants encoded by ubiquitin pseudogenes. McGill Seminars. Canada.
  • (2018). Functions of Ubiquitin and Novel Ubiquitin Variants in DNA Replication and Repair. Charbonneau Special Seminar. Calgary, Canada.
  • (2017). Cell Biology Through Proteomics in Space and Time. CFABS - 2017 Toronto Spring Mass Spectrometry Group Meeting. Canada.
  • (2016). Spatial Proteomics – where cell biology meets mass spectrometry. Seminar - Sick Kids Hospital, University of Toronto. Toronto, Canada.
  • (2016). The Proteomics of Colorectal Cancer: Identification of a Protein Signature Associated with Prognosis. Canadian Digestive Diseases Week 2016. Montreal, Canada.
  • (2015). Comprehensive characterization of Minichromosome Maintenance Complex (MCM) protein interactions using affinity and proximity purifications coupled to mass spectrometry. Department of Gene Regulation and Expression Seminars. Dundee, United Kingdom.
  • (2015). Le rôle du complexe MCM dans la réponse cellulaire aux dommages à l’ADN. CRCQ 2015. Sacacomie, Canada.
  • (2014). Dynamics of protein interactions of the MCM complex in response to DNA damage. Sixth Annual Canadian National Proteomics Network Symposium. Montreal, Canada.
  • (2014). Dynamique des interactions du complexe MCM en réponse aux dommages à l'ADN. Signalisation Québec. Bécancour, Canada.
  • (2013). La redistribution subcellulaire des protéines en réponse aux dommages à l’ADN : un rôle pour le complexe MCM dans la réparation de l’ADN. L'Institut du Cancer de Montréal et le Centre de Recherche du CHUM seminars. Montreal, Canada.
  • (2013). Omics/Proteomics of Colorectal Cancer. Canadian Digestive Disease Week 2013 (CDDW 2013). Victoria, Canada.
  • (2013). Proteomic Analysis of Human Intestinal Epithelial Cells. 10th Symposium on the Physiology and Diseases of the Digestive Tract. Magog, Canada.
  • (2013). Une approche protéomique pour étudier la redistribution subcellulaire des protéines en réponse aux dommages à l'ADN. Invited speaker, Centre de Recherche du CHUQ (CHUL). Québec, Canada.
  • (2012). De Montréal à Sherbrooke, un voyage de 10,000 km à travers la science!. Journal Club, Department of Anatomy and Cell Biology, Université de Sherbrooke. Sherbrooke, Canada.
  • (2012). Dynamics of protein interactions during the cellular response to DNA damage. 19th Methods in Protein Structure Analysis Conference. Ottawa, Canada.
  • (2011). A Quantitative Spatial Proteomic Analysis of Proteome Turnover in Human Cancer Cells. Cancer Proteomics EMBO Meeting. Dublin, Ireland.
  • (2010). A Quantitative Proteomic Analysis of Protein Subcellular Localization and Turnover. Proteomics of Chromatin and Nucleur Structures Joint Meeting. St-Andrews, United Kingdom.
  • (2010). A Quantitative Proteomic Analysis of changes in Subcellular Localization Following DNA damage. Lady Davis Institute Seminars. Montreal, Canada.
  • (2010). A Quantitative Proteomic Approach for Measuring the Subcellular Distribution of Proteins. 1st Workshop in Chromatin Proteomics. Munich, Germany.
  • (2009). A Quantitative Proteomic Analysis of Changes in Subcellular Localization Induced by DNA Damage. Wilhelm Bernhard Workshop (The 21st International Workshop on the Cell Nucleus). Ustron, Poland.
  • (2009). Determination of Protein Turover in Different Cellular Compartment by Pulse SILAC. Wellcome Trust Centre for Gene Regulation and Expression Inaugural Symposium. Dundee, United Kingdom.
  • (2008). Spatial Proteomics: A Quantitative Annotation of Protein Localization. 5th Joint BSPR/EBI Proteomics Meeting. Hinxton, United Kingdom.
  • (2007). 2nd Generation Proteomics: A Quantitative Annotation of Protein Localization, dynamic and interaction partners. Fourth Proteomics Methods Forum. Liverpool, United Kingdom.
  • (2006). Changes in the Nucleolar Proteome Through the Cell Cycle. Dynamic Organization of Nuclear Function Meeting. Cold Spring Harbor, United States.
  • (2005). Arginine Methylation of MRE11 by PRMT1 is required for the intra-S-phase DNA damage checkpoint. 3rd annual meeting of the Montreal Centre for Experimental Therapeutics in Cancer. Montréal, Canada.
  • (2004). Arginine Methylation Targets the MRE11/RAD50/NBS1 Complex to Sites of DNA Damage. Mechanisms of Genomic Integrity (EMBO). Galway, Ireland.
  • (1998). Characterization of a Nuclear Structure Highly Enriched in CBP-HAT. Twentieth Annual West Coast Chromatin and Chromosomes Meeting. Pacific Grove, United States.

Les informations disponibles dans la base de données Expertus sont tirées du CV commun canadien.